Published in J Mol Model on March 01, 2006
Fluorescent saxitoxins for live cell imaging of single voltage-gated sodium ion channels beyond the optical diffraction limit. Chem Biol (2012) 1.50
The evolutionary origins of beneficial alleles during the repeated adaptation of garter snakes to deadly prey. Proc Natl Acad Sci U S A (2009) 1.24
Sodium channelopathies and pain. Pflugers Arch (2010) 1.22
Constraint shapes convergence in tetrodotoxin-resistant sodium channels of snakes. Proc Natl Acad Sci U S A (2012) 1.03
A pore-blocking hydrophobic motif at the cytoplasmic aperture of the closed-state Nav1.7 channel is disrupted by the erythromelalgia-associated F1449V mutation. J Biol Chem (2008) 0.98
Genetic architecture of a feeding adaptation: garter snake (Thamnophis) resistance to tetrodotoxin bearing prey. Proc Biol Sci (2010) 0.93
De novo synthesis of modified saxitoxins for sodium ion channel study. J Am Chem Soc (2009) 0.88
Mechanism of sodium channel block by local anesthetics, antiarrhythmics, and anticonvulsants. J Gen Physiol (2017) 0.87
Functional and structural diversification of the Anguimorpha lizard venom system. Mol Cell Proteomics (2010) 0.87
Effects of marine toxins on the reproduction and early stages development of aquatic organisms. Mar Drugs (2010) 0.87
New gastropod vectors and tetrodotoxin potential expansion in temperate waters of the Atlantic Ocean. Mar Drugs (2012) 0.86
Serine-401 as a batrachotoxin- and local anesthetic-sensing residue in the human cardiac Na+ channel. Pflugers Arch (2007) 0.84
Marked difference in saxitoxin and tetrodotoxin affinity for the human nociceptive voltage-gated sodium channel (Nav1.7) [corrected]. Proc Natl Acad Sci U S A (2012) 0.83
Synthesis and biological evaluation of a fluorescent analog of phenytoin as a potential inhibitor of neuropathic pain and imaging agent. Bioorg Med Chem (2012) 0.78
Indoxacarb, Metaflumizone, and Other Sodium Channel Inhibitor Insecticides: Mechanism and Site of Action on Mammalian Voltage-Gated Sodium Channels. Pestic Biochem Physiol (2013) 0.76
Mutant cycle analysis with modified saxitoxins reveals specific interactions critical to attaining high-affinity inhibition of hNaV1.7. Proc Natl Acad Sci U S A (2016) 0.75
SWISS-MODEL and the Swiss-PdbViewer: an environment for comparative protein modeling. Electrophoresis (1997) 57.27
The structure of the potassium channel: molecular basis of K+ conduction and selectivity. Science (1998) 39.86
Local anesthetics: hydrophilic and hydrophobic pathways for the drug-receptor reaction. J Gen Physiol (1977) 12.38
The permeability of the sodium channel to organic cations in myelinated nerve. J Gen Physiol (1971) 10.25
Crystal structure and mechanism of a calcium-gated potassium channel. Nature (2002) 10.03
From ionic currents to molecular mechanisms: the structure and function of voltage-gated sodium channels. Neuron (2000) 9.51
The open pore conformation of potassium channels. Nature (2002) 9.09
Structural parts involved in activation and inactivation of the sodium channel. Nature (1989) 8.72
Existence of distinct sodium channel messenger RNAs in rat brain. Nature (1986) 7.87
Cation-pi interactions in structural biology. Proc Natl Acad Sci U S A (1999) 6.88
Molecular determinants of state-dependent block of Na+ channels by local anesthetics. Science (1994) 5.62
A cluster of hydrophobic amino acid residues required for fast Na(+)-channel inactivation. Proc Natl Acad Sci U S A (1992) 5.60
A tetrodotoxin-resistant voltage-gated sodium channel expressed by sensory neurons. Nature (1996) 4.63
Mapping the site of block by tetrodotoxin and saxitoxin of sodium channel II. FEBS Lett (1991) 3.29
Identification of an intracellular peptide segment involved in sodium channel inactivation. Science (1988) 3.04
Common molecular determinants of local anesthetic, antiarrhythmic, and anticonvulsant block of voltage-gated Na+ channels. Proc Natl Acad Sci U S A (1996) 3.03
A single point mutation confers tetrodotoxin and saxitoxin insensitivity on the sodium channel II. FEBS Lett (1989) 2.73
Energetics of ion conduction through the gramicidin channel. Proc Natl Acad Sci U S A (2003) 2.67
A structural model of the tetrodotoxin and saxitoxin binding site of the Na+ channel. Biophys J (1994) 2.64
Amino acid residues required for fast Na(+)-channel inactivation: charge neutralizations and deletions in the III-IV linker. Proc Natl Acad Sci U S A (1992) 2.45
The receptor for tetrodotoxin and saxitoxin. A structural hypothesis. Biophys J (1975) 2.27
The voltage-sensitive sodium channel is a bell-shaped molecule with several cavities. Nature (2001) 2.23
Molecular determinants of voltage-dependent gating and binding of pore-blocking drugs in transmembrane segment IIIS6 of the Na(+) channel alpha subunit. J Biol Chem (2001) 2.20
Characterization of TTX-sensitive and TTX-resistant sodium currents in small cells from adult rat dorsal root ganglia. J Physiol (1993) 2.16
QXP: powerful, rapid computer algorithms for structure-based drug design. J Comput Aided Mol Des (1997) 1.97
Role of amino acid residues in transmembrane segments IS6 and IIS6 of the Na+ channel alpha subunit in voltage-dependent gating and drug block. J Biol Chem (2002) 1.95
KcsA crystal structure as framework for a molecular model of the Na(+) channel pore. Biochemistry (2000) 1.76
Kinetic basis for insensitivity to tetrodotoxin and saxitoxin in sodium channels of canine heart and denervated rat skeletal muscle. Biochemistry (1987) 1.60
The position of the fast-inactivation gate during lidocaine block of voltage-gated Na+ channels. J Gen Physiol (1999) 1.50
Interaction of batrachotoxin with the local anesthetic receptor site in transmembrane segment IVS6 of the voltage-gated sodium channel. Proc Natl Acad Sci U S A (1998) 1.45
Modeling P-loops domain of sodium channel: homology with potassium channels and interaction with ligands. Biophys J (2004) 1.40
Differences in saxitoxin and tetrodotoxin binding revealed by mutagenesis of the Na+ channel outer vestibule. Biophys J (1998) 1.35
Solution structure of the sodium channel inactivation gate. Biochemistry (1999) 1.31
Point mutations at N434 in D1-S6 of mu1 Na(+) channels modulate binding affinity and stereoselectivity of local anesthetic enantiomers. Mol Pharmacol (1999) 1.31
Involvement of the C terminus in intramolecular nitrogen channeling in glucosamine 6-phosphate synthase: evidence from a 1.6 A crystal structure of the isomerase domain. Structure (1998) 1.30
A common local anesthetic receptor for benzocaine and etidocaine in voltage-gated mu1 Na+ channels. Pflugers Arch (1998) 1.29
Lysine point mutations in Na+ channel D4-S6 reduce inactivated channel block by local anesthetics. Mol Pharmacol (1998) 1.28
Divalent cation competition with [3H]saxitoxin binding to tetrodotoxin-resistant and -sensitive sodium channels. A two-site structural model of ion/toxin interaction. J Gen Physiol (1993) 1.23
Role of outer ring carboxylates of the rat skeletal muscle sodium channel pore in proton block. J Physiol (2002) 1.12
A critical residue for isoform difference in tetrodotoxin affinity is a molecular determinant of the external access path for local anesthetics in the cardiac sodium channel. Proc Natl Acad Sci U S A (2000) 1.05
Interactions of the C-11 hydroxyl of tetrodotoxin with the sodium channel outer vestibule. Biophys J (2003) 1.05
Influence of negative surface charge on toxin binding to canine heart Na channels in planar bilayers. Biophys J (1989) 1.04
Commentary: A revised view of local anesthetic action: what channel state is really stabilized? J Gen Physiol (1999) 0.91
Developing three-dimensional models of ion channel proteins. Ion Channels (1996) 0.89
The guanidinium toxin binding site on the sodium channel. Jpn Heart J (1996) 0.75
SWISS-MODEL: An automated protein homology-modeling server. Nucleic Acids Res (2003) 25.86
High-throughput SHAPE analysis reveals structures in HIV-1 genomic RNA strongly conserved across distinct biological states. PLoS Biol (2008) 4.40
A geographic variant of the Staphylococcus aureus Panton-Valentine leukocidin toxin and the origin of community-associated methicillin-resistant S. aureus USA300. J Infect Dis (2008) 2.76
Crystal structure of human cytochrome P450 2D6. J Biol Chem (2005) 2.34
Genome-wide RNA polymerase II profiles and RNA accumulation reveal kinetics of transcription and associated epigenetic changes during diurnal cycles. PLoS Biol (2012) 2.12
Definition of the G protein-coupled receptor transmembrane bundle binding pocket and calculation of receptor similarities for drug design. J Med Chem (2009) 1.37
Small and intermediate conductance Ca(2+)-activated K+ channels confer distinctive patterns of distribution in human tissues and differential cellular localisation in the colon and corpus cavernosum. Naunyn Schmiedebergs Arch Pharmacol (2004) 1.32
Upregulation of the voltage-gated sodium channel beta2 subunit in neuropathic pain models: characterization of expression in injured and non-injured primary sensory neurons. J Neurosci (2005) 1.29
Evolutionary trajectories of primate genes involved in HIV pathogenesis. Mol Biol Evol (2009) 1.23
Progesterone receptor ligand binding pocket flexibility: crystal structures of the norethindrone and mometasone furoate complexes. J Med Chem (2004) 1.16
Heterologous expression and functional analysis of rat Nav1.8 (SNS) voltage-gated sodium channels in the dorsal root ganglion neuroblastoma cell line ND7-23. Neuropharmacology (2004) 1.08
Hyaline fibromatosis syndrome inducing mutations in the ectodomain of anthrax toxin receptor 2 can be rescued by proteasome inhibitors. EMBO Mol Med (2011) 1.08
1,2,4-triazol-3-yl-thiopropyl-tetrahydrobenzazepines: a series of potent and selective dopamine D(3) receptor antagonists. J Med Chem (2007) 1.02
Defining and searching for structural motifs using DeepView/Swiss-PdbViewer. BMC Bioinformatics (2012) 1.00
Natural variation of potato allene oxide synthase 2 causes differential levels of jasmonates and pathogen resistance in Arabidopsis. Planta (2008) 0.99
2-[2-(3,4-dichloro-phenyl)-2,3-dihydro-1H-isoindol-5-ylamino]-nicotinic acid (PD-307243) causes instantaneous current through human ether-a-go-go-related gene potassium channels. Mol Pharmacol (2007) 0.98
TIE-2 and VEGFR kinase activities drive immunosuppressive function of TIE-2-expressing monocytes in human breast tumors. Clin Cancer Res (2013) 0.97
1,2,4-Triazolyl azabicyclo[3.1.0]hexanes: a new series of potent and selective dopamine D(3) receptor antagonists. J Med Chem (2010) 0.92
Improved functional expression of recombinant human ether-a-go-go (hERG) K+ channels by cultivation at reduced temperature. BMC Biotechnol (2007) 0.92
CCR2: characterization of the antagonist binding site from a combined receptor modeling/mutagenesis approach. J Med Chem (2003) 0.91
Activation of SK channels inhibits epileptiform bursting in hippocampal CA3 neurons. Brain Res (2005) 0.90
Synthesis and pharmacological characterization of novel druglike corticotropin-releasing factor 1 antagonists. J Med Chem (2008) 0.85
Density-based hierarchical clustering of pyro-sequences on a large scale--the case of fungal ITS1. Bioinformatics (2013) 0.85
Modeling GPCR active state conformations: the β(2)-adrenergic receptor. Proteins (2011) 0.85
Structural determinants of drugs acting on the Nav1.8 channel. J Biol Chem (2009) 0.84
Expression of the sodium channel beta3 subunit in injured human sensory neurons. Neuroreport (2004) 0.83
A missense mutation in myelin oligodendrocyte glycoprotein as a cause of familial narcolepsy with cataplexy. Am J Hum Genet (2011) 0.82
Plant species distributions along environmental gradients: do belowground interactions with fungi matter? Front Plant Sci (2013) 0.81
In vitro profiling against ion channels beyond hERG as an early indicator of cardiac risk. Curr Opin Mol Ther (2009) 0.80
G-protein-coupled receptor dynamics: dimerization and activation models compared with experiment. Biochem Soc Trans (2012) 0.78
Modeling active GPCR conformations. Methods Enzymol (2013) 0.78
Expression, purification, and characterization of multiple, multifunctional human glucocorticoid receptor proteins. Protein Expr Purif (2008) 0.78
Novel 384-well population patch clamp electrophysiology assays for Ca2+-activated K+ channels. J Biomol Screen (2006) 0.78
Functional analysis of CYP2D6.31 variant: homology modeling suggests possible disruption of redox partner interaction by Arg440His substitution. Proteins (2005) 0.78
Population patch-clamp electrophysiology analysis of recombinant GABAA alpha1beta3gamma2 channels expressed in HEK-293 cells. J Biomol Screen (2009) 0.77
Dihydropyrrole[2,3-d]pyridine derivatives as novel corticotropin-releasing factor-1 antagonists: mapping of the receptor binding pocket by in silico docking studies. J Med Chem (2008) 0.77
3,4-Dihydro-2H-benzoxazinones as dual-acting 5-HT1A receptor antagonists and serotonin reuptake inhibitors. Bioorg Med Chem Lett (2006) 0.76
GNB5 Mutations Cause an Autosomal-Recessive Multisystem Syndrome with Sinus Bradycardia and Cognitive Disability. Am J Hum Genet (2016) 0.76
Recurrent structural motifs in non-homologous protein structures. Int J Mol Sci (2013) 0.75
Functional and pharmacological properties of human and rat NaV1.8 channels. Neuropharmacology (2009) 0.75
A standardized clinical evaluation of phenotypic diversity in diabetic polyneuropathy. Pain (2016) 0.75
Decreased potassium channel IK1 and its regulator neurotrophin-3 (NT-3) in inflamed human bowel. Neuroreport (2003) 0.75
Ask the experts: future of the pharmaceutical industry. Interview by Future Medicinal Chemistry. Future Med Chem (2011) 0.75
Evidence for the proximity of the extreme N-terminus of the neurokinin-2 (NK2) tachykinin receptor to Cys167 in the putative fourth transmembrane helix. Biochemistry (2004) 0.75
Novel 5-HT(1A/1B/1D) receptors antagonists with potent 5-HT reuptake inhibitory activity. Bioorg Med Chem Lett (2008) 0.75
Luminescence screening assays for the identification of sensitizers for lanthanides based on the controlled formation of ternary lanthanide complexes with DTPA-bisamide ligands. Chem Asian J (2010) 0.75
Discovery of novel 1-azoniabicyclo[2.2.2]octane muscarinic acetylcholine receptor antagonists. J Med Chem (2009) 0.75
Design, synthesis, and structure-activity relationship of tropane muscarinic acetylcholine receptor antagonists. J Med Chem (2009) 0.75